Fairmount Funds Management LLC Diversified Active

Location: West Conshohocken, PA

CIK: 0001802528 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 8, 2020

Total Value: $165M (100.0% shares, 0.0% debt)

Holdings (14)

ACAD ACADIA PHARMACEUTICALS INC 15.5%

Value $25.5M Shares 603,517 Est. Cost $43.17 Unrealized -4.6%

— ZOGENIX INC 14.6%

Value $24.03M Shares 971,875 Est. Cost $37.89 Unrealized —

INSM INSMED INC 9.9%

Value $16.36M Shares 1,020,797 Est. Cost $20.45 Unrealized +15.9%

IOVA IOVANCE BIOTHERAPEUTICS INC 8.9%

Value $14.71M Shares 491,390 Est. Cost $23.03 Unrealized +15.1%

FOLD AMICUS THERAPEUTICS INC 7.5%

Value $12.38M Shares 1,340,395 Est. Cost $9.51 Unrealized 0.0%

AXSM AXSOME THERAPEUTICS INC 6.8%

Value $11.15M Shares 189,598 Est. Cost $81.48 Unrealized 0.0%

— KARYOPHARM THERAPEUTICS INC 6.6%

Value $10.8M Shares 562,351 Est. Cost $19.18 Unrealized —

ARGX ARGENX SE 6.1%

Value $10.1M Shares 76,638 Est. Cost $160.52 Unrealized —

— NEOLEUKIN THERAPEUTICS INC 5.6%

Value $9.219M Shares 810,073 Est. Cost $12.32 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 5.3%

Value $8.74M Shares 169,949 Est. Cost $61.59 Unrealized -13.5%

— ALLAKOS INC 4.8%

Value $7.949M Shares 178,662 Est. Cost $81.12 Unrealized —

— TRILLIUM THERAPEUTICS INC 4.5%

Value $7.345M Shares 1,818,181 Est. Cost $4.04 Unrealized —

— AMARIN CORP PLC 2.1%

Value $3.487M Shares 871,714 Est. Cost $20.84 Unrealized —

— KINIKSA PHARMACEUTICALS LTD 1.9%

Value $3.098M Shares 200,125 Est. Cost $11.83 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACAD	ACADIA PHARMACEUTICALS INC	603,517	$25.5M	15.5%	$43.17	-4.6%	COM	004225108
—	ZOGENIX INC	971,875	$24.03M	14.6%	$37.89	—	COM NEW	98978L204
INSM	INSMED INC	1,020,797	$16.36M	9.9%	$20.45	+15.9%	COM PAR $.01	457669307
IOVA	IOVANCE BIOTHERAPEUTICS INC	491,390	$14.71M	8.9%	$23.03	+15.1%	COM	462260100
FOLD	AMICUS THERAPEUTICS INC	1,340,395	$12.38M	7.5%	$9.51	0.0%	COM	03152W109
AXSM	AXSOME THERAPEUTICS INC	189,598	$11.15M	6.8%	$81.48	0.0%	COM	05464T104
—	KARYOPHARM THERAPEUTICS INC	562,351	$10.8M	6.6%	$19.18	—	COM	48576U106
ARGX	ARGENX SE	76,638	$10.1M	6.1%	$160.52	—	SPONSORED ADR	04016X101
—	NEOLEUKIN THERAPEUTICS INC	810,073	$9.219M	5.6%	$12.32	—	COM	64049K104
ENTA	ENANTA PHARMACEUTICALS INC	169,949	$8.74M	5.3%	$61.59	-13.5%	COM	29251M106
—	ALLAKOS INC	178,662	$7.949M	4.8%	$81.12	—	COM	01671P100
—	TRILLIUM THERAPEUTICS INC	1,818,181	$7.345M	4.5%	$4.04	—	COM NEW	89620X506
—	AMARIN CORP PLC	871,714	$3.487M	2.1%	$20.84	—	SPONS ADR NEW	023111206
—	KINIKSA PHARMACEUTICALS LTD	200,125	$3.098M	1.9%	$11.83	—	COM CL A	G5269C101